Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial.
Saved in:
| Title: | Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial. |
|---|---|
| Authors: | Liu, Dan1 (AUTHOR), Zhou, Jun2 (AUTHOR), Wang, Yongsheng3 (AUTHOR), Li, Mingjun4 (AUTHOR), Jiang, Haiping5 (AUTHOR), Liu, Yunpeng6 (AUTHOR), Yin, Xianli7 (AUTHOR), Ge, Minghua8 (AUTHOR), Xiang, Xiaojun9 (AUTHOR), Ying, Jieer10 (AUTHOR), Huang, Jian11 (AUTHOR), Zhang, Yan-qiao12 (AUTHOR), Cheng, Ying13 (AUTHOR), Huang, Zhigang14 (AUTHOR), Yuan, Xianglin15 (AUTHOR), Han, Weiqing16 (AUTHOR), Yan, Dong17 (AUTHOR), Wang, Xinshuai18 (AUTHOR), Liu, Pan19 (AUTHOR), Wang, Linna19 (AUTHOR) |
| Source: | BMC Medicine. 10/24/2022, Vol. 20 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159838344 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Liu%2C+Dan%22">Liu, Dan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Jun%22">Zhou, Jun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yongsheng%22">Wang, Yongsheng</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Mingjun%22">Li, Mingjun</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Haiping%22">Jiang, Haiping</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yunpeng%22">Liu, Yunpeng</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yin%2C+Xianli%22">Yin, Xianli</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ge%2C+Minghua%22">Ge, Minghua</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xiang%2C+Xiaojun%22">Xiang, Xiaojun</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ying%2C+Jieer%22">Ying, Jieer</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Jian%22">Huang, Jian</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yan-qiao%22">Zhang, Yan-qiao</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Ying%22">Cheng, Ying</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Zhigang%22">Huang, Zhigang</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yuan%2C+Xianglin%22">Yuan, Xianglin</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+Weiqing%22">Han, Weiqing</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yan%2C+Dong%22">Yan, Dong</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xinshuai%22">Wang, Xinshuai</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Pan%22">Liu, Pan</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Linna%22">Wang, Linna</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 10/24/2022, Vol. 20 Issue 1, p1-11. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159838344 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12916-022-02605-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Titles: – TitleFull: Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu, Dan – PersonEntity: Name: NameFull: Zhou, Jun – PersonEntity: Name: NameFull: Wang, Yongsheng – PersonEntity: Name: NameFull: Li, Mingjun – PersonEntity: Name: NameFull: Jiang, Haiping – PersonEntity: Name: NameFull: Liu, Yunpeng – PersonEntity: Name: NameFull: Yin, Xianli – PersonEntity: Name: NameFull: Ge, Minghua – PersonEntity: Name: NameFull: Xiang, Xiaojun – PersonEntity: Name: NameFull: Ying, Jieer – PersonEntity: Name: NameFull: Huang, Jian – PersonEntity: Name: NameFull: Zhang, Yan-qiao – PersonEntity: Name: NameFull: Cheng, Ying – PersonEntity: Name: NameFull: Huang, Zhigang – PersonEntity: Name: NameFull: Yuan, Xianglin – PersonEntity: Name: NameFull: Han, Weiqing – PersonEntity: Name: NameFull: Yan, Dong – PersonEntity: Name: NameFull: Wang, Xinshuai – PersonEntity: Name: NameFull: Liu, Pan – PersonEntity: Name: NameFull: Wang, Linna IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 10 Text: 10/24/2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 17417015 Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: BMC Medicine Type: main |
| ResultId | 1 |